The extent of an exogenously administered bioactive molecule's sustained availability in the intended final site of action determines its potency and efficacy. Drug Delivery strategies have contributed to the conversion of potential therapeutics into effective treatments. DDSs are pharmaceutical formulations or systems that aid in the targeted delivery and/or controlled release (CR) of therapeutic agents in living organisms. Potential physical-chemical or enzymatic disruptions of the therapeutic agent are reduced by enclosing the molecules in a protective shell-like structure. DDSs regulate the rate of drug release and absorption, as well as the therapeutic and adverse effects of the drug. Ideal DDSs assure that the active medication is present at the site of action for the duration required by the patient. Delivery techniques and technologies swiftly changed to accommodate changing drug delivery needs as the therapeutic landscape altered.
- Controlled Drug Delivery System
- Ocular Drug Delivery System
- 2D & 3D Printing in Drug Delivery
- Drug Delivery: Devices and Equipment
- Nano Drug Delivery Systems
A C Matin
Stanford University, United States
Tudor Arvinte
Biopharmaceutics University of Geneva, Switzerland
Richard Denk
SKAN AG, Switzerland
Consolato M Sergi
University of Ottawa, Canada
Ruchika Bajaj
University of California, United States
Bhupendra Gopalbhai Prajapati
Shree S.K.Patel College of Pharmaceutical Education and Research, India
Dasharath Muljibhai Patel
Graduate School of Pharmacy, IndiaSubmit your abstract Today
Title : Microemulsion based in situ gel of erythromycin for ocular ailments
Dasharath Muljibhai Patel, Graduate School of Pharmacy, India
Title : Nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Thymoquinone-induced cellular and mitochondrial health in hepatocellular and cholangiocellular carcinoma
Consolato M Sergi, University of Ottawa, Canada
Title : Points to consider for the manufacturing of cell and gene therapies
Richard Denk, SKAN AG, Switzerland
Title : Pharmacological features of sparsentan, a novel dual endothelin and angiotensin receptor antagonist
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Development and validation of RP-HPLC method for the dissolution study of tofacitinib in pharmaceutical solid dosage form
Narapereddy Krishna Prasad, Reckitt Benckiser LLC, United States
Title : Does erector spinae plane block improve respiratory outcomes in adults with rib fractures?
Katie Aldred, University of Liverpool, United Kingdom
Title : Interdisciplinary perspective towards therapeutic potential in antenatal care
Anita, DMIHER, India
Title : Augmented anti-atopic dermatitis effect of crisaborole nanoemulgel in 2,4-Di-nitrochlorobenzene induced (DNCB) atopic dermatitis (AD) in Balb/c mice
Dipti Srivastava, Hygia institute of pharmaceutical education and research, India
Title : Formulation, characterization and evaluation: Micellar loaded complex of cuminum cyminum to treat causing disease of COVID 19 (Respiratory Infection)
Rudra Pratap Singh Rajput, Royal College of Pharmacy, India